Assessment of pulmonary infectious disease treatment with Mongolian medicine formulae based on data mining, network pharmacology and molecular docking

被引:18
|
作者
Zhou, Baochang [1 ]
Qian, Zhanhong [1 ]
Li, Qinyu [2 ]
Gao, Yuan [3 ]
Li, Minhui [1 ,2 ,4 ,5 ]
机构
[1] Inner Mongolia Med Univ, Coll Tradit Chinese Med, Hohhot 010110, Peoples R China
[2] Baotou Med Coll, Dept Pharm, Baotou 014040, Peoples R China
[3] Inner Mongolia Med Univ, Inner Mongolia Autonomous Reg Hosp Tradit Chinese, Clin Coll Tradit Chinese Med, Hohhot 010020, Peoples R China
[4] Inner Mongolia Inst Tradit Chinese & Mongolian Med, Hohhot 010010, Peoples R China
[5] Baotou Med Coll, Inner Mongolia Key Lab Characterist Geoherbs Resou, Baotou 014040, Peoples R China
基金
中国国家自然科学基金;
关键词
data mining; Mongolian medicine; network pharmacology; pulmonary tuberculosis; viral pneumonia; PNEUMONIA;
D O I
10.1016/j.chmed.2022.07.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Pulmonary infectious diseases (PID) include viral pneumonia (VP) and pulmonary tuberculosis (PT). Mongolian medicine (MM) is an effective treatment option in China, however, the core group medicines (CGMs) in the treatment of PID and their underlying therapeutic mechanisms remain unclear. In this study, through the method of data mining, the CGMs of MM for the treatment of PID were exca-vated, and the possible mechanism of action of the CGMs in the treatment of PID was explored by using network pharmacology.Methods: First, 89 MM formulae for the treatment of pulmonary infectious diseases collected from Gan Lu Si Bu, Meng Yi Jin Kui, People's Republic of China Ministry of Health Drug Standards (Mongolian Medicine Volume), Standard of Mongolian Medicine Preparations in Inner Mongolia (2007 Edition), and Standard of Mongolian Medicine Preparations in Inner Mongolia (2014 Edition). The CGMs of MM for PID were exca-vated through association rule analysis and cluster analysis. Then, the active ingredients and potential targets of the CGMs were obtained from TCMSP, TCMIP, BATMAN-TCM databases. PID targets information was collected from OMIM, GeneCards, and DrugBank databases. The possible targets of CGMs treatment for PID were obtained by intersection. The PPI network was constructed through the STRING database, and the topology analysis of the network was performed. Through the enrichment analysis of the inter-section targets by R language, the main action pathways and related target proteins of CGMs in the treat-ment of PID were screened out. The results were verified by molecular docking.Results: A total of 89 formulae were included, involving 164 MM herbs. The efficacy of the drugs was mainly cough-suppressing and panting-calming herbs, and heat-clearing herbs. The nature and flavor were mainly bitter and cold. The CGMs of MM to treatment of PID was excavated as the classic famous formula Sanzi Decoction (Toosendan Fructus-Chebulae Fructus-Gardeniae Fructus). A total of 28 candidate components and 237 predicted targets of CGMs were collected, and 61 common targets with PID were obtained, including key compounds such as quercetin, kaempferol, b-sitosterol and stigmastero and key targets such as VEGFA, IL6, TP53, AKT1. KEGG enrichment analysis yielded AGE-RAGE signaling path-ways, IL-17 signaling pathways, and TNF signaling pathways. Molecular docking results showed that the key targets were well matched with the potential active ingredients of CGMs.Conclusion: This study found that MM commonly used cough-suppressing and panting-calming herbs in combination with heat-clearing herbs to treat PID, and the CGMs for the treatment of PID is "Toosendan Fructus-Chebulae Fructus-Gardeniae Fructus". CGMs mainly play a role in the treatment of PID by acting on VEGFA, IL6, TP53, AKT1 and other targets, regulating AGE-RAGE signaling pathways, IL-17 signaling path-ways, and TNF signaling pathways.(c) 2022 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:432 / 448
页数:17
相关论文
共 50 条
  • [41] Exploring the Active Compounds of Traditional Mongolian Medicine Baolier Capsule (BLEC) in Patients with Coronary Artery Disease (CAD) Based on Network Pharmacology Analysis, Molecular Docking and Experimental Validation
    Wei, Mengqiu
    Li, Fengjin
    Guo, Kai
    Yang, Tianxiao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 459 - 476
  • [42] Mechanisms predictive of Tibetan Medicine Sophora moorcroftiana alkaloids for treatment of lung cancer based on the network pharmacology and molecular docking
    Ji, Peng
    Zhao, Nian-Shou
    Wu, Fan-Lin
    Wei, Yan-Ming
    Laba, Ci-Dan
    Wujin, Cuo-Mu
    Hua, Yong-Li
    Yuan, Zi-Wen
    Yao, Wan-Ling
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
  • [43] Network pharmacology and molecular docking analysis on the mechanism of Wensan tincture in the treatment of pulmonary nodules: A review
    Zhang, Jinzhi
    Yang, Jingqi
    Li, Guangxi
    MEDICINE, 2024, 103 (48)
  • [44] Mechanisms predictive of Tibetan Medicine Sophora moorcroftiana alkaloids for treatment of lung cancer based on the network pharmacology and molecular docking
    Peng Ji
    Nian-Shou Zhao
    Fan-Lin Wu
    Yan-Ming Wei
    Ci-Dan Laba
    Cuo-Mu Wujin
    Yong-Li Hua
    Zi-Wen Yuan
    Wan-Ling Yao
    BMC Complementary Medicine and Therapies, 24
  • [45] Network pharmacology and molecular docking-based investigation on traditional Chinese medicine Astragalus membranaceus in oral ulcer treatment
    Zhong, Wan
    Tao, Si-Yu
    Guo, Xiang
    Cheng, Xiao-Fang
    Yuan, Qing
    Li, Chu-Xing
    Tian, Hong-Yuan
    Yang, Song
    Sunchuri, Diwas
    Guo, Zhu-Ling
    MEDICINE, 2023, 102 (34) : E34744
  • [46] Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking
    Zhao, Jinlong
    Lin, Fangzheng
    Liang, Guihong
    Han, Yanhong
    Xu, Nanjun
    Pan, Jianke
    Luo, Minghui
    Yang, Weiyi
    Zeng, Lingfeng
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [47] The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies
    Xin, G.
    Yuedong, Y.
    Xuemei, S.
    Chenhan, M.
    Meng, Z.
    Chenbo, Z.
    Ning, G.
    Xindong, W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (07) : 2478 - 2488
  • [48] Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation
    Shengnan Chen
    Bo Li
    Lei Chen
    Hongli Jiang
    Journal of Translational Medicine, 21
  • [49] Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking
    Yu, Xiaoming
    Qin, Wenxiang
    Cai, Haijian
    Ren, Chufan
    Huang, Shengjing
    Lin, Xiao
    Tang, Lin
    Shan, Zhuohan
    AL-Ameer, Wail Hussein Ahmed
    Wang, Liangxing
    Yan, Hanhan
    Chen, Mayun
    COMPUTERS IN BIOLOGY AND MEDICINE, 2024, 169
  • [50] Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation
    Chen, Shengnan
    Li, Bo
    Chen, Lei
    Jiang, Hongli
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)